Related Experiment Videos
Economic evaluation of neonatal screening for congenital dislocation of the hip
1Department of Orthopaedic Surgery, B.C. Children's Hospital, Vancouver, Canada.
Insights
Neonatal screening for dislocatable and subluxable hips offers significant economic benefits. Early detection and treatment of hip conditions in newborns provide a direct financial advantage to healthcare institutions.
Area of Science:
- Orthopedics
- Neonatal care
- Health economics
Background:
- Established safety and efficacy of early treatment for neonatal hip conditions.
- Previous studies confirm benefits of timely intervention for dislocatable and subluxable hips.
Purpose of the Study:
- To determine the cost-benefit of neonatal screening for dislocatable and subluxable hips.
- To quantify the economic advantages of implementing a neonatal hip screening program.
Main Methods:
- Analysis of retrospective and prospective data.
- Evaluation of economic impact on participating healthcare institutions.
Main Results:
- Neonatal hip screening programs demonstrate direct and significant economic benefits.
- Grace and Children's Hospitals in British Columbia reported savings of $15,143.71 CAD per 1,000 infants screened.
Conclusions:
- Implementing neonatal screening for hip conditions is economically advantageous for hospitals.
- The study highlights the financial viability of early detection and treatment protocols for infantile hip dysplasia.
Abstract:
A study was undertaken to determine the cost benefit of neonatal screening for dislocatable and subluxable hips. As a follow-up to retrospective and prospective studies that established the safety and efficacy of early treatment to the newborn, this study discusses the direct and significant economic benefit of a neonatal hip screening program to the participating institutions. British Columbia's Grace and Children's Hospitals experienced an economic benefit of $15,143.71 (Canadian) per 1,000 infants screened.